The UK Center of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on the use ...
Bristol-Myers Squibb and Sanofi’s Plavix was the top-selling drug in the first quarter of 2012, but it’s time on top may not last long. Bristol-Myers Squibb and Sanofi’s Plavix was the top-selling ...
A commonly prescribed drug could be more effective than aspirin for long-term heart disease prevention. Analysis of nearly 29,000 patients with coronary artery disease (CAD) suggests the blood thinner ...
CHICAGO (Reuters) - A common gene variation explains why many people are not helped by the widely prescribed blood thinner Plavix, U.S. researchers said on Tuesday in a study confirming earlier ...
CHICAGO -- For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as aspirin monotherapy in a high-risk ...
NEW YORK, Oct 23 (Reuters) - A small study presented on Monday suggests Eli Lilly and Co.'s experimental blood clot preventer, prasugrel, works faster and could be more effective than the commonly ...
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 20 new drugs in its recent meeting, under the provisions of the Drugs Prices Control Order (DPCO), 2013, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results